Competitive Technologies, Inc. Announces Presentation at American Urological Association
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
FAIRFIELD, Conn., June 19, 2013 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced an update regarding Xion Pharmaceuticals ("Xion"), a joint venture with CTTC formed in 2010 to advance the commercialization of Melanotan-II (MT-II) peptides especially for sexual dysfunction.
Help employers find you! Check out all the jobs and post your resume.
FAIRFIELD, Conn., June 19, 2013 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced an update regarding Xion Pharmaceuticals ("Xion"), a joint venture with CTTC formed in 2010 to advance the commercialization of Melanotan-II (MT-II) peptides especially for sexual dysfunction.
Help employers find you! Check out all the jobs and post your resume.